JUN and breast cancer: Our studies confirm the importance of the extracellular domain of EpCAM in EPCAM signaling; addition of recombinant extracellular EpCAM rescues breast cancer invasion, AP-1 transcription factor activity, and c-Jun phosphorylation in a dose-dependent fashion following specific ablation of EpCAM.